Chiesi Global Rare Diseases and Protalix BioTherapeutics Announce Launch of Expanded Access …
BOSTON and CARMIEL, Israel, Oct. 02, 2020 (GLOBE NEWSWIRE) -- Chiesi Global Rare Diseases, a business unit of Chiesi Farmaceutici...
Protalix
BOSTON and CARMIEL, Israel, Oct. 02, 2020 (GLOBE NEWSWIRE) -- Chiesi Global Rare Diseases, a business unit of Chiesi Farmaceutici...
